Drugs / Cromolyn
Cromolyn
also known as
Cromolyn Sodium · Sodium Cromoglicate · Cromoglicate · Acide cromoglicique · Acido cromoglicico · Aerocrom · Allercrom · ALZT-OP1a · +53 more
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | NASALCROM | — | 2001-03-27 | fda.gov ↗ |
| Label expansion | US (FDA) | OPTICROM | — | 1993-06-11 | fda.gov ↗ |
| Approved | US (FDA) | INTAL | — | 1982-05-28 | fda.gov ↗ |
Trials 21
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT07757555 | Nov 2026 → Dec 2027 expected | dysautonomia, postural orthostatic tachycardia syndrome | Johns Hopkins University | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT03167216 | Aug 2017 → Apr 2022 | chronic prostatitis | Northwestern University | Completed | No outcome recorded |
| Phase 15 trials | ||||||
| Phase 1 | NCT07675876 | Aug 2026 → Jun 2027 expected | lung adenocarcinoma | Carcinex Inc | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT04570644 | Aug 2020 → Jan 2021 | Alzheimer disease | AZTherapies, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT04007120 | Oct 2019 → May 2020 | lung disorder | Respivant Sciences GmbH | Completed | No outcome recorded |
| Phase 1 | NCT02566252 | Jul 2015 → Jan 2016 | — | Pulmotect, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01841307 | Jul 2015 → Mar 2017 | gastroesophageal reflux disease, idiopathic pulmonary fibrosis | University of California, San Francisco | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01933464 | Aug 2013 → Feb 2014 | rosacea | University of California, San Diego | Completed | No outcome recorded |
| Phase 29 trials · 1 met primary | ||||||
| Phase 2 | NCT07419880 | Jan → Dec 2027 expected | triple-negative breast carcinoma | Fudan University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07526558 | Apr 2026 → Jan 2027 expected | tick-borne infectious disease | University of North Carolina, Chapel Hill | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07142291 | Nov 2025 → Mar 2027 expected | amyotrophic lateral sclerosis | PhenoNet, Inc. | Recruiting | No outcome recorded |
| Phase 2 | NCT05076682 | Jun 2022 → Dec 2026 expected | triple-negative breast carcinoma | Fudan University | Recruiting | Met primary |
| Phase 2 | NCT04846348 | Jul → Sep 2021 | cutaneous mastocytosis | Joseph Butterfield | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT02412020 | Feb 2015 → Jan 2016 | upper respiratory tract disorder | Patara Pharma | Completed | Mixed |
| Phase 2 | NCT01722812 | Nov 2012 → Apr 2013 | psoriasis | LEO Pharma | Completed | No outcome recorded |
| Phase 2 | NCT01701843 | Oct 2012 → Feb 2013 | mastocytosis | LEO Pharma | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT00745199 | May → Nov 2008 | end stage renal failure | Shiraz University of Medical Sciences | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT06801626 | Mar 2025 → Dec 2027 expected | — | The University of Texas Medical Branch, Galveston | Recruiting | No outcome recorded |
| Phase 3 | NCT05077917 | Nov 2021 → May 2024 | COVID-19, viral pneumonia | Texas Tech University Health Sciences Center, El Paso | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT04408664 | Apr 2021 → Jun 2023 | exercise-induced bronchoconstriction | Universitaire Ziekenhuizen KU Leuven | Terminated | No outcome recorded Stop: Enrollment |
| Phase 41 trial · 1 missed | ||||||
| Phase 4 | NCT02371941 | Dec 2014 → Jul 2017 | eosinophilic esophagitis | University of Tennessee | Completed | Missed primary |
| Comparator or background therapy3 trials | ||||||
| Phase 1/2 | NCT03794076 Comparator | Apr 2019 → Jan 2028 expected | schizoaffective disorder, schizophrenia | Vishwajit Nimgaonkar, MD PhD | Recruiting | No outcome recorded |
| Phase 2 | NCT03202147 Comparator | Dec 2023 → Dec 2024 | cognitive disorder, ischemic stroke | AZTherapies, Inc. | Withdrawn | No outcome recorded |
| Phase 3 | NCT01175525 Comparator | — | stroke disorder | Wolfson Medical Center | Unknown | No outcome recorded |
Evidence & citations 65 cited values
Every value below carries the sentence it was read from. 25 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cromolyn | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04570644 ↗ |
| Known as | Acide cromoglicique | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Acido cromoglicico | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Aerocrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Allercrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | ALZT-OP1a | “ALZT-OP1a (cromolyn) and ALZT-OP1b (ibuprofen)” NCT04570644 ↗ |
| Known as | Aspire | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Astilyn | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Brol-eze | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Catacrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Clariteyes | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Crolom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromo-comod | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromogen | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromogen e-breathe | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromoglicate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01722812 ↗ |
| Known as | Cromoglicate sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromoglicic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromoglycate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03794076 ↗ |
| Known as | Cromoglycic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromolux | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromolyn disodium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromolyn Sodium | “RVT-1601, a new inhalation formulation of cromolyn sodium delivered via the eFlow® Closed System (CS) nebulizer/face mask.” NCT04007120 ↗ |
| Known as | Cromolyn, Intal, Cromolyn Sodium, Sodium cromoglycate | “Cromolyn, Intal, Cromolyn Sodium, Sodium cromoglycate” NCT04570644 ↗ |
| Known as | Cromoptic | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromosol | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cromosol optha | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Cusilyn | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Disodium cromolyn | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Dominion pharma hayfever | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Eye-crom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | FPL-670 | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Gastrocrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Glycavent | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Gppe syncroner inha | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Hay-crom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Intal | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Intal 5 | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Lomudal | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Lomusol | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Murine | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Nalcrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Nasalcrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Natrii cromoglicas | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | NSC-109500 | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Opticrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Opticrom aq | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | R03BC01 | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Resiston one | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Resiston treatment pack | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | RVT-1601 | “RVT-1601, a new inhalation formulation of cromolyn sodium delivered via the eFlow® Closed System (CS) nebulizer/face mask.” NCT04007120 ↗ |
| Known as | Rynacrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Rynacrom allergy | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Rynacrom co | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | SCG | “Sodium Cromoglycate (SCG) (Lomudal®)” NCT04408664 ↗ |
| Known as | Sodium Cromoglicate | “PA101 is a novel formulation of sodium cromoglicate delivered via a high-efficiency eFlow nebuliser that achieves significantly higher drug deposition in the lung compared with...” PMID 28923239 ↗ Sep 20172“Sodium Cromoglicate 10 mg/mL packed in ampulla of 2 mL; Daily dosis of 4X20 mg milligram delivered by aerosol.” NCT04408664 ↗ |
| Known as | Sodium Cromoglycate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04408664 ↗ |
| Known as | sodium cromolyn | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04846348 ↗ |
| Known as | Steri-neb cromogen | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Vivicrom | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Vividrin | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Known as | Viz-on | ChEMBL registry synonym — accepted as the source's own label CHEMBL428880 ↗ |
| Action | Inhibit | “mast cell inhibitor” NCT03794076 ↗ |
| Modality | Small molecule | — CHEMBL428880 ↗ |
| Route | Oral | “oral cromolyn sodium, capsule 135mg, 1 capsule 3 times daily for 8 weeks” NCT00745199 ↗ |